Allogene Therapeutics, Inc. (ALLO)

NMS – Цена в реальном времени. Валюта: USD

2.07

-0.05 (-2.36%)

При закрытии: Aug 12, 2026, 4:00 PM EDT

2.16

+0.09 (4.35%)

После закрытия: Aug 12, 2026, 4:35 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

04.08.2026

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

SOUTH SAN FRANCISCO, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today announced that it will report second quarter 2026 financial results and provide a business update on August 12, 2026, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET.

Видео

No Data

There is no data to display

Allogene Therapeutics, Inc. (ALLO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Видео

No Data

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Видео

No Data

Search stocks

Allogene Therapeutics, Inc. (ALLO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Видео

No Data

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Видео

No Data